New Randomised Control Trial Evidence Confirms Repose® as Gold Standard for Pressure Ulcer Prevention

Published in the International Journal of Nursing Studies, Professor Dimitri Beeckman and his team, have compared the effectiveness of the Repose, static air support system versus alternating air pressure support surfaces, in a nursing home population at high risk of pressure ulcers.

Pressure Ulcer (PU) prevalence in nursing homes across Europe has been stated as high as 31.4%10 and continues to pose significant challenges to caregivers in all care settings. The results of this RCT show that Repose was significantly more effective in PU prevention, resulted in more days being pressure ulcer free and had a lower purchase cost when compared to alternating air pressure mattresses.

“The results speak for themselves”, Simon Jackson, Managing Director at Frontier Medical Group confirms “over the last 20 years, Repose has consistently shown low levels of pressure ulcer incidence across multiple studies in multiple care settings and the results from the latest RCT, only go to prove what we have always known – Repose works.

The study shows that high-risk patients are twice as likely to sustain pressure damage from the use of dynamic systems1, so Repose should be considered the gold standard for pressure ulcer prevention, for any patient at risk, when used as part of a package of care.”

Repose is a range of static air, pressure redistribution and reduction support surfaces, all with high levels of immersion and envelopment. A combination of unique materials and Smart Valve Technology has been clinically proven to deliver statistically significant patient benefits1-9.

Unlike, other static air and dynamic systems, as proven in through Randomised Control Trials, Repose reduces peak and average pressures and consistently delivers low levels of pressure ulcer incidence, in a cost-effective, easy to use system1-9.

For more information, visit www.frontier-group.co.uk or follow @FMG_Group on Twitter.

About Frontier

Frontier Medical Group Frontier Medical Group, based in Blackwood, South Wales, is a market leading provider of a range of specialist medical devices to healthcare professionals and end users both in the UK and internationally. Frontier’s products contribute significantly to the safety and wellbeing of end users and patients, specifically in Skin/Wound Care and Infection Prevention. Its main product lines are:

 

Repose® – A range of pressure area care devices (including mattresses overlays, cushions and foot protectors) used in both the treatment and prevention of pressure ulcers.

 

Toto® – A unique, patented automated patient turning platform used for patient repositioning as part of a pressure area care programme.

 

Dermisplus® Prevent – A range of pressure redistributing pads used in the prevention and treatment of pressure ulcers.

 

Sharpsafe® – A range of containers for the safe disposal of clinical sharps which have evolved in line with healthcare and legislative infection control requirements.

 

Exchange® – A variety of products developed to meet the growing demand for specialised equipment and paraphernalia for needle exchange and harm reduction programmes.

 

  1. Beeckman et al. (2018) A multi-centre prospective randomised controlled clinical trial to compare the effectiveness and cost of a static air mattress and alternating air pressure mattress to prevent pressure ulcers in high-risk nursing home residents. International Journal of Nursing Studies, June, https://doi.org/10.1016/j.ijnurstu.2019.05.015
  2. Van Leen, M. Hovius, S. Neyens, J. Hafens, R, Shols, J. (2011) Pressure relief, cold foam or static air? A single centre, prospective, controlled randomised clinical trial in a Dutch nursing home. Journal of Tissue Viability, 20 (1), 30-34
  3. Beeckman et al. (2016) Static air support surfaces to prevent pressure injuries. J Wound Ostomy Continence Nurs. 2016;43(4):375-378
  4. Van Leen et al. (2013) Pressure Relief with Visco-Elastic Foam or with Combined Static Air Overlay? A prospective, Crossover Randomized Clinical Trial in a Dutch Nursing Home. Wounds 2013;25(10):287-292
  5. Price, P. et al. (1999) Challenging the pressure sore paradigm. JWC April, Vol 8, No 4
  6. Osterbrink J, et al. (2005) Clinical evaluation of the effectiveness of a multimodal static pressure relieving device. 8th EPUAP Open meeting, Aberdeen
  7. Price, P, et al. (2003) The use of a new overlay mattress in patients with chronic pain: impact on sleep and self-reported pain. Clin Rehabil 2003;17:488- 92
  8. Macfarlane, A. Sayer, S. (2006) Two clinical evaluations of the Repose system. Wounds UK; 2:14-25
  9. Gaffing, J. (2016) Repose Foot Care Solutions: A 12 month Strategy to Reduce Hospital Acquired Heel Pressure Ulcers (HAPU) at the University Hospitals Of Morecambe Bay NHS Foundation Trust. Poster presented at Wounds UK, Harrogate.
  10. Beeckman D, Mathei C, Van Lancker A, Van Houdt S, Van Walleghem G, Gryson L et al. Een nationale richtlijn voor decubituspreventie. Good Clinical Practice (GCP) 2013; Available from; https://kce.fgov.be/nl/een-nationale-richtlijn-voor-decubituspreventie